Ipca Laboratories Ltd gains for fifth session

April 23, 2026 · 1:05 pm IST Source: Business Standard
๐Ÿ“Œ

Key Takeaways

  • Ipca Laboratories Ltd is quoting at Rs 1537.9, up 2.88% on the day as on 12:44 IST on the NSE.
  • The stock is up 6.38% in last one year as compared to a 0.19% spurt in NIFTY and a 4.48% spurt in the Nifty Pharma.
  • The stock is quoting at Rs 1537.9, up 2.88% on the day as on 12:44 IST on the NSE.
  • The benchmark NIFTY is down around 0.72% on the day, quoting at 24201.65.

Full Report

Ipca Laboratories Ltd is quoting at Rs 1537.9, up 2.88% on the day as on 12:44 IST on the NSE. The stock is up 6.38% in last one year as compared to a 0.19% spurt in NIFTY and a 4.48% spurt in the Nifty Pharma.
Ipca Laboratories Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 1537.9, up 2.88% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.72% on the day, quoting at 24201.65. The Sensex is at 77776.44, down 0.94%. Ipca Laboratories Ltd has risen around 0.46% in last one month.
Meanwhile, Nifty Pharma index of which Ipca Laboratories Ltd is a constituent, has risen around 3.23% in last one month and is currently quoting at 22455.45, up 2.24% on the day. The volume in the stock stood at 1.24 lakh shares today, compared to the daily average of 2.45 lakh shares in last one month.
The PE of the stock is 37.83 based on TTM earnings ending December 25.

Originally reported by Business Standard.
๐Ÿ’ก

IPO Cracker Take

Broader market sentiment often dictates IPO timing and subscription strength. We track live subscription data across Mainboard and SME issues so you can gauge appetite in real time.

โ“

Frequently Asked Questions

Market news feeds into IPO pricing decisions, subscription timing, and listing-day sentiment. Track the broader market daily alongside each active IPO's own fundamentals.

Our IPO calendar shows all upcoming, open, and recently listed issues in one place — with price band, GMP, and subscription data.

We publish daily market and IPO news, live GMP updates, and subscription tracking. Bookmark our News page or follow us on social media for real-time updates.
0 Comments

No comments yet. Be the first to share your opinion!